Entia Biosciences, Inc.
OTC: ERGO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Timothy A. Timmins
- Employees
- 6
- Headquarters
- Sherwood, United States
- IPO year
- 2008
- Market cap
- $6.7K
- Website
- https://www.entra.no
Loading ERGO…
Loading profile data…Frequently asked questions about ERGO
What does Entia Biosciences, Inc. (ERGO) do?
Entia Biosciences, Inc. engages in the development, production, and distribution of dietary supplements, nutraceuticals, and medical food products in the United States. The company develops ErgoD2, a pharmaceutical grade organic compound for the improvement of iron homeostasis and mitigation of iron-related disorders presenting in anemia, chroni...
Where does ERGO trade?
Entia Biosciences, Inc. (ERGO) trades on the Other OTC.
What sector is ERGO in?
Entia Biosciences, Inc. (ERGO) operates in the Healthcare sector, specifically in the Medical - Pharmaceuticals industry.
Who is the CEO of Entia Biosciences, Inc.?
Timothy A. Timmins is the chief executive officer of Entia Biosciences, Inc. (ERGO).
Where is Entia Biosciences, Inc. headquartered?
Entia Biosciences, Inc. is headquartered in United States.
Does ERGO pay a dividend?
Entia Biosciences, Inc. (ERGO) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ERGO go public?
Entia Biosciences, Inc. (ERGO) completed its initial public offering in 2008.